The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
FZD7 has a critical role in cell proliferation in triple negative breast cancer
Open accessAbstract
Breast cancer is genetically and clinically heterogeneous. Triple negative breast cancer (TNBC) is a subtype of breast cancer that is usually associated with poor outcome and lack of benefit from targeted therapy. We used microarray analysis to perform a pathway analysis of TNBC compared with non-triple negative breast cancer (non-TNBC). Overexpression of several Wnt pathway genes, such as frizzled homolog 7 (FZD7), low density lipoprotein receptor-related protein 6 and transcription factor 7 (TCF7) was observed in TNBC, and we directed our focus to the Wnt pathway receptor, FZD7. To validate the function of FZD7, FZD7shRNA was used to knock down FZD7 expression. Notably, reduced cell proliferation and suppressed invasiveness and colony formation were observed in TNBC MDA-MB-231 and BT-20 cells. Study of the possible mechanism indicated that these effects occurred through silencing of the canonical Wnt signaling pathway, as evidenced by loss of nuclear accumulation of β-catenin and decreased transcriptional activity of TCF7. In vivo studies revealed that FZD7shRNA significantly suppressed tumor formation, through reduced cell proliferation, in mice bearing xenografts without FZD7 expression. Our findings suggest that FZD7-involved canonical Wnt signaling pathway is essential for tumorigenesis of TNBC, and thus, FZD7 shows promise as a biomarker and a potential therapeutic target for TNBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Wnt signal transduction pathways
Komiya, Y., & Habas, R. (2008) · Organogenesis · doi:10.4161/org.4.2.5851 · Cited by 1,528 · cited 6×
“In our microarray data, we noticed that two genes, FZD and PKCB1, along the non-canonical Wnt/Ca2þ pathway were upregulated in TNBC.”
BackgroundInfluentialA new member of the frizzled family from Drosophila functions as a Wingless receptor
Bhanot, P., Brink, M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., Andrew, D., Nathans, J., & Nusse, R. (1996) · Nature · doi:10.1038/382225a0 · Cited by 1,502
Self-citationAn LDL-receptor-related protein mediates Wnt signalling in mice
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086
LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:Arrows point the way
He, X., Semenov, M., Tamai, K., & Zeng, X. (2004) · Development · doi:10.1242/dev.01117 · Cited by 1,044
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Silver, D. P., Richardson, A. L., Eklund, A. C., Wang, Z. C., Szallasi, Z., Li, Q., Juul, N., Leong, C.-O., Calogrias, D., Buraimoh, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4725 · Cited by 981
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
Bafico, A., Liu, G., Yaniv, A., Gazit, A., & Aaronson, S. A. (2001) · Nature Cell Biology · doi:10.1038/35083081 · Cited by 772
Triple-negative breast cancer—current status and future directions
Gluz, O., Liedtke, C., Gottschalk, N., Pusztai, L., Nitz, U., & Harbeck, N. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp492 · Cited by 687
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
Anders, C. K., & Carey, L. A. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.s.008 · Cited by 625
Kassam, F., Enright, K., Dent, R., Dranitsaris, G., Myers, J., Flynn, C., Fralick, M., Kumar, R., & Clemons, M. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.n.005 · Cited by 474
DiMeo, T. A., Anderson, K., Phadke, P., Feng, C., Perou, C. M., Naber, S., & Kuperwasser, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4135 · Cited by 414
Wg/Wnt Signal Can Be Transmitted through Arrow/LRP5,6 and Axin Independently of Zw3/Gsk3β Activity
Tolwinski, N. S., Wehrli, M., Rives, A., Erdeniz, N., DiNardo, S., & Wieschaus, E. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00063-7 · Cited by 286 · cited 2×
“…Wnt signaling, FZD binds to Dishevelled (DVL) and LRP5/6-binds to AXIN-FRAT to form a complex. b-catenin is prevented from phosphorylation (Tolwinski et al., 2003) and the stabilized b-catenin translocates from the cytoplasm to the nucleus to activate transcription of Wnt-responsive genes…”
BackgroundCKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling
Price, M. A. (2006) · Genes & Development · doi:10.1101/gad.1394306 · Cited by 257
Ojalvo, L. S., Whittaker, C. A., Condeelis, J. S., & Pollard, J. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902360 · Cited by 238
Wnt Signaling Pathway in Mammary Gland Development and Carcinogenesis
Turashvili, G., Bouchal, J., Burkadze, G., & Kolar, Z. (2006) · Pathobiology · doi:10.1159/000098207 · Cited by 207
LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
Liu, C.-C., Prior, J., Piwnica-Worms, D., & Bu, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911220107 · Cited by 207
Hoseong Yang, S., Andl, T., Grachtchouk, V., Wang, A., Liu, J., Syu, L.-J., Ferris, J., Wang, T. S., Glick, A. B., Millar, S. E., et al. (2008) · Nature Genetics · doi:10.1038/ng.192 · Cited by 195
Wnt signaling in breast cancer: have we come full circle?
Brown, A. M. C. (2001) · Breast Cancer Research · doi:10.1186/bcr321 · Cited by 147
The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development
Lindvall, C. J., Diegel, C. R., Evans, N. C., West, R. A., Dykema, K. J., Furge, K. A., & Williams, B. O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005813 · Cited by 137
Lee, F. S., Lane, T. F., Kuo, A. C., Shackleford, G. M., & Leder, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2268 · Cited by 122
Sonderegger, S., Husslein, H., Leisser, C., & Knöfler, M. (2007) · Placenta · doi:10.1016/j.placenta.2006.11.003 · Cited by 118
Wnt Signaling, Stem Cells, and the Cellular Origin of Breast Cancer
Lindvall, C. J., Bu, W., Williams, B. O., & Li, Y. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0025-3 · Cited by 104
Chapter 3 The TRAIL to Targeted Therapy of Breast Cancer
Rahman, M., Pumphrey, J. G., & Lipkowitz, S. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)03003-6 · Cited by 89
Stem/Progenitor Cells in Mouse Mammary Gland Development and Breast Cancer
Li, Y., & Rosen, J. M. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-2537-2 · Cited by 73
Adjuvant therapy of triple negative breast cancer
Perez, E. A., Moreno‐Aspitia, A., Thompson, E. A., & Andorfer, C. A. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0736-z · Cited by 56
Wnt-induced proteolytic targeting: Figure 1.Preprint
Jones, K. A., & Kemp, C. R. (2008) · Genes & Development · doi:10.1101/gad.1741008 · Cited by 7
Cited by
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Polakis, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008052 · Cited by 847
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Wang, Y., Zhang, T., Kwiatkowski, N., Abraham, B. J., Lee, T. I., Xie, S., Yuzugullu, H., Von, T., Li, H., Lin, Z., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.063 · Cited by 465
Self-citationGong, C., Tian, J., Wang, Z., Gao, Y., Wu, X., Ding, X., Qiang, L., Li, G., Han, Z., Yuan, Y., et al. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0526-7 · Cited by 339
Self-citation
Metadata
- Authors
- Yang, L., Wu, X., Wang, Y., Zhang, K., Wu, J., Yuan, Y.-C., Deng, X., Chen, L., Kim, C. C. H., Lau, S., Somlo, G., & Yen, Y.
- Venue
- Oncogene
- Published
- 2011-05-02
- Volume
- 30
- Issue
- 43
- Pages
- 4437-4446
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1996900960
- Cited by
- 297
- References
- 32
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.